The global pediatric clinical trial market is set for substantial growth over the next decade, according to a new report. The market, valued at USD 16,831.0 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024, reaching a remarkable USD 31,661.0 million by 2034. This follows an impressive CAGR of 6.5% from 2019 to 2023.
The increasing need for tailored medical treatments for children and advancements in pediatric healthcare are key drivers of this growth. The market’s expansion underscores the growing recognition of the importance of pediatric-specific clinical trials in developing safe and effective treatments for children.
Your Insightful Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15017
Oncology’s therapeutic field category had the second-highest worldwide sales share in 2021. Globally, cancer is the leading cause of mortality. By 2040, there will likely be 291,000 new instances of cancer among children under the age of 19. The number of pediatric clinical trials is rising globally as a result of hospitals and other institutions concentrating on the development of therapeutic medications in response to the rising number of childhood cancer cases worldwide.
The worldwide market for pediatric clinical trials may be hampered for a variety of reasons even with all of these growing considerations. The pediatric clinical trial market is expected to grow slowly due to the high number of study terminations for various reasons. Children’s research frequently falls short because
Pivotal Pediatric Clinical Trial Providers:
- Synteract
- ICON Plc.
- Syneos Health
- Medpace, Inc
- PPD Inc.
- Premier Research
- LabCorp Drug Development
- QPS Holding
- Pfizer Inc.
- The Emmes Company, LLC
- IQVIA Inc.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15017
Key Market Segmentation:
By Area:
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Respiratory Diseases
- Diabetes
- HIV
- Others
By Sponsor:
- Industry
- Government Organizations
- Non-Government Organizations
- Associations
- Others
By Phases:
- Phase 1
- Phase 2
- Phase 3
- Phase 4
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- MEA
In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15017
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
